Captrust Financial Advisors Sage Therapeutics, Inc. Transaction History

Captrust Financial Advisors

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$40.65 - $59.54 $20,406 - $29,889	502 Added 8.98%	6,091 $286,000
Q1 2023 May 15, 2023	BUY	$37.27 - $46.57 $208,302 - $260,279	5,589 New	5,589 $234,000
Q2 2022 Aug 23, 2022	SELL	$27.52 - $37.99 $1,073 - $1,481	-39 Reduced 8.84%	402 $13,000
Q2 2022 Aug 16, 2022	SELL	$27.52 - $37.99 $4,320 - $5,964	-157 Reduced 26.25%	441 $14,000
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $11,301 - $16,821	368 Added 160.0%	598 $20,000
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $7,745 - $9,845	-209 Reduced 47.61%	230 $10,000
Q3 2021 Nov 16, 2021	SELL	$40.26 - $57.37 $3,583 - $5,105	-89 Reduced 16.86%	439 $19,000
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $658 - $951	12 Added 2.33%	528 $30,000
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $27,341 - $37,446	-387 Reduced 42.86%	516 $39,000
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $46,085 - $70,268	789 Added 692.11%	903 $78,000
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $2,958 - $4,919	114 New	114 $5,000
Q3 2018 Nov 15, 2018	SELL	$138.11 - $169.04 $552 - $676	-4 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$140.36 - $175.76 $1,263 - $1,581	-9 Reduced 69.23%	4 $1,000
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $1,977 - $2,500	13 New	13 $2,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.